{"id":"https://openalex.org/W4315435258","doi":"https://doi.org/10.1002/ajh.26831","title":"A phase II study of combination daunorubicin, cytarabine (Ara\u2010c), and nilotinib ( TAsigna ) ( DATA ) in patients newly diagnosed with acute myeloid leukemia with KIT expression","display_name":"A phase II study of combination daunorubicin, cytarabine (Ara\u2010c), and nilotinib ( TAsigna ) ( DATA ) in patients newly diagnosed with acute myeloid leukemia with KIT expression","publication_year":2023,"publication_date":"2023-01-10","ids":{"openalex":"https://openalex.org/W4315435258","doi":"https://doi.org/10.1002/ajh.26831","pmid":"https://pubmed.ncbi.nlm.nih.gov/36625066"},"language":"en","primary_location":{"id":"doi:10.1002/ajh.26831","doi":"https://doi.org/10.1002/ajh.26831","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ajh.26831","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.26831","source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.26831","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008422091","display_name":"Aref Al\u2010Kali","orcid":"https://orcid.org/0000-0002-0824-3715","observed_orcids":["https://orcid.org/0000-0002-0824-3715"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Aref Al\u2010Kali","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA"],"raw_orcid":"https://orcid.org/0000-0002-0824-3715","affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018041025","display_name":"Raoul Tibes","orcid":"https://orcid.org/0000-0002-1372-8733","observed_orcids":["https://orcid.org/0000-0002-1372-8733"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I4210126310","display_name":"Universit\u00e4tsklinikum W\u00fcrzburg","ror":"https://ror.org/03pvr2g57","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210126310"]}],"countries":["DE","GB"],"is_corresponding":false,"raw_author_name":"Raoul Tibes","raw_affiliation_strings":["AstraZeneca, Cambridge, UK","Department of Internal Medicine II University Hospital of W\u00fcrzburg  W\u00fcrzburg Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Department of Internal Medicine II University Hospital of W\u00fcrzburg  W\u00fcrzburg Germany","institution_ids":["https://openalex.org/I4210126310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107094424","display_name":"Pamela J. Atherton","orcid":"https://orcid.org/0000-0002-8078-337X","observed_orcids":["https://orcid.org/0000-0002-8078-337X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela Atherton","raw_affiliation_strings":["Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057941081","display_name":"Jeanne M. Palmer","orcid":"https://orcid.org/0000-0002-2185-1504","observed_orcids":["https://orcid.org/0000-0002-2185-1504"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeanne Palmer","raw_affiliation_strings":["Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, Arizona, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, Arizona, USA","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064856519","display_name":"Hassan B. Alkhateeb","orcid":"https://orcid.org/0000-0002-3609-8404","observed_orcids":["https://orcid.org/0000-0002-3609-8404"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hassan B. Alkhateeb","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072463255","display_name":"Mrinal M. Patnaik","orcid":"https://orcid.org/0000-0001-6998-662X","observed_orcids":["https://orcid.org/0000-0001-6998-662X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mrinal Patnaik","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA"],"raw_orcid":"https://orcid.org/0000-0001-6998-662X","affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080965667","display_name":"Kebede H. Begna","orcid":"https://orcid.org/0000-0003-2730-8593","observed_orcids":["https://orcid.org/0000-0003-2730-8593"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kebede Begna","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA"],"raw_orcid":"https://orcid.org/0000-0003-2730-8593","affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002643270","display_name":"Naseema Gangat","orcid":"https://orcid.org/0000-0002-9104-6172","observed_orcids":["https://orcid.org/0000-0002-9104-6172"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naseema Gangat","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA"],"raw_orcid":"https://orcid.org/0000-0002-9104-6172","affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043033429","display_name":"Shahrukh Khurshid Hashmi","orcid":"https://orcid.org/0000-0002-8914-7927","observed_orcids":["https://orcid.org/0000-0002-8914-7927"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shahrukh Hashmi","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079731167","display_name":"Rong Lucy He","orcid":"https://orcid.org/0000-0001-6116-8163","observed_orcids":["https://orcid.org/0000-0001-6116-8163","https://orcid.org/0000-0002-6011-5964"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rong He","raw_affiliation_strings":["Division of hematopathology, Mayo Clinic, Rochester, Minnesota, USA"],"raw_orcid":"https://orcid.org/0000-0001-6116-8163","affiliations":[{"raw_affiliation_string":"Division of hematopathology, Mayo Clinic, Rochester, Minnesota, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085360755","display_name":"Mark Robert Litzow","orcid":"https://orcid.org/0000-0002-9816-6302","observed_orcids":["https://orcid.org/0000-0002-9816-6302"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Litzow","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA"],"raw_orcid":"https://orcid.org/0000-0002-9816-6302","affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5008422091"],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":4940,"currency":"USD","value_usd":4940},"apc_paid":null,"fwci":1.4413,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.81632183,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"98","issue":"3","first_page":"472","last_page":"480"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":1.0},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":0.8669999837875366},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.996999979019165},{"id":"https://openalex.org/keywords/kit-expression","display_name":"KIT expression","score":0.8709999918937683},{"id":"https://openalex.org/keywords/c-kit","display_name":"CD117","score":0.9470000267028809},{"id":"https://openalex.org/keywords/multikinase-inhibitor","display_name":"multikinase inhibitor","score":0.8360000252723694},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.7730000019073486},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9810000061988831},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.6050000190734863},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.6970000267028809},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.8560000061988831},{"id":"https://openalex.org/keywords/liver-failure","display_name":"liver failure","score":0.4020000100135803}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.832353413105011},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.7604526281356812},{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.659299373626709},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6179965734481812},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.5726870894432068},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5483643412590027},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5464266538619995},{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.5113477110862732},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5034121870994568},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.44454994797706604},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.435336709022522},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37890541553497314},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3446961045265198},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.16201746463775635},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.15293145179748535},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.13898169994354248},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003630","descriptor_name":"Daunorubicin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/ajh.26831","doi":"https://doi.org/10.1002/ajh.26831","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ajh.26831","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.26831","source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},{"id":"pmid:36625066","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36625066","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of hematology","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":{"id":"doi:10.1002/ajh.26831","doi":"https://doi.org/10.1002/ajh.26831","is_oa":true,"landing_page_url":"https://doi.org/10.1002/ajh.26831","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.26831","source":{"id":"https://openalex.org/S199810014","display_name":"American Journal of Hematology","issn_l":"0361-8609","issn":["0361-8609","1096-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4315435258.pdf","grobid_xml":"https://content.openalex.org/works/W4315435258.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1979895715","https://openalex.org/W2023381080","https://openalex.org/W2070609585","https://openalex.org/W2078964293","https://openalex.org/W2083614603","https://openalex.org/W2087783849","https://openalex.org/W2094912768","https://openalex.org/W2101157786","https://openalex.org/W2110828128","https://openalex.org/W2134892135","https://openalex.org/W2137881702","https://openalex.org/W2142830602","https://openalex.org/W2147083172","https://openalex.org/W2151978874","https://openalex.org/W2154625299","https://openalex.org/W2156027275","https://openalex.org/W2159507916","https://openalex.org/W2177270897","https://openalex.org/W2285786982","https://openalex.org/W2318674152","https://openalex.org/W2339658711","https://openalex.org/W2591748434","https://openalex.org/W2624339255","https://openalex.org/W2715749014","https://openalex.org/W2739363814","https://openalex.org/W2904378474","https://openalex.org/W2915860404"],"related_works":["https://openalex.org/W4205377048","https://openalex.org/W2586788687","https://openalex.org/W2909642323","https://openalex.org/W2285786982","https://openalex.org/W1506738181","https://openalex.org/W4405053282","https://openalex.org/W2980010922","https://openalex.org/W2555630829","https://openalex.org/W795592684","https://openalex.org/W2604623195"],"abstract_inverted_index":{"Acute":[0],"myeloid":[1],"leukemia":[2],"(AML)":[3],"is":[4,38,44],"a":[5,78,121,129,211],"challenging":[6],"cancer":[7],"in":[8,85,146,185,203,218],"terms":[9],"of":[10,150,159],"achieving":[11],"and":[12,28,72,89,178,208],"maintaining":[13],"long-duration":[14],"remissions.":[15],"Many":[16],"novel":[17],"therapies":[18],"have":[19],"been":[20],"added":[21],"to":[22,33,96,98,188,195,214],"the":[23,75],"standard":[24],"regimen":[25],"(combining":[26],"cytarabine":[27,70],"anthracycline":[29],"\"7":[30],"+":[31,63],"3\")":[32],"achieve":[34],"such":[35],"goals.":[36],"Nilotinib":[37],"an":[39,50],"oral":[40],"multikinase":[41],"inhibitor":[42],"that":[43,219],"active":[45],"against":[46],"KIT":[47,90],"tyrosine":[48],"kinase,":[49],"important":[51],"stem":[52],"cell":[53,101],"target.":[54],"In":[55],"this":[56,116],"trial,":[57],"we":[58],"combined":[59],"nilotinib":[60],"with":[61,87,115],"7":[62],"3":[64,168],"induction":[65,186],"(daunorubicin":[66],"60":[67],"mg/m2),":[68],"high-dose":[69],"consolidation,":[71],"subsequently,":[73],"if":[74,104],"patient":[76,182],"was":[77,110,144,192],"candidate,":[79],"for":[80],"2":[81],"years'":[82],"maintenance":[83],"therapy":[84],"patients":[86,119,137,153,204],"AML":[88],"(CD117)":[91],"expression.":[92],"Patients":[93],"were":[94,126],"allowed":[95],"proceed":[97],"allogeneic":[99,155],"hematopoietic":[100],"transplantation":[102],"(HCT)":[103],"deemed":[105],"necessary.":[106],"Our":[107,197],"primary":[108],"goal":[109],"increased":[111],"complete":[112,141],"remission":[113,142],"rate":[114,143],"combination.":[117],"Thirty-four":[118],"(with":[120],"median":[122],"age":[123],"58.5":[124],"years)":[125],"enrolled":[127],"on":[128],"single-arm":[130],"phase":[131],"II":[132],"bi-institutional":[133],"study;":[134],"21":[135],"(62%)":[136],"achieved":[138],"remission.":[139],"The":[140],"78%":[145],"evaluable":[147],"patients.":[148],"Thirteen":[149],"34":[151],"(38%)":[152],"had":[154],"HCT,":[156],"all":[157],"thirteen":[158],"which":[160,191],"are":[161],"still":[162],"alive":[163],"(100%).":[164],"Common":[165],"(>20%)":[166],"grade":[167],"non-hematological":[169],"toxicities":[170],"included":[171],"febrile":[172],"neutropenia,":[173],"hypophosphatemia,":[174],"elevated":[175],"liver":[176,189],"enzymes,":[177],"hypertension.":[179],"Only":[180],"one":[181],"(3%)":[183],"died":[184],"due":[187],"failure,":[190],"thought":[193],"secondary":[194],"daunorubicin.":[196],"current":[198],"study":[199,213],"reveals":[200],"good":[201],"outcomes":[202],"who":[205],"received":[206],"HCT":[207],"may":[209],"warrant":[210],"larger":[212],"confirm":[215],"our":[216],"findings":[217],"specific":[220],"population.":[221]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2023-01-11T00:00:00"}